Cargando…

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells

Standard of care for Epithelial Ovarian Cancer (EOC) patients relies on platinum-based therapy. However, acquired resistance to platinum occurs frequently and predicts poor prognosis. To understand the mechanisms underlying acquired platinum-resistance, we have generated and characterized three plat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sonego, Maura, Pellizzari, Ilenia, Dall’Acqua, Alessandra, Pivetta, Eliana, Lorenzon, Ilaria, Benevol, Sara, Bomben, Riccardo, Spessotto, Paola, Sorio, Roberto, Gattei, Valter, Belletti, Barbara, Schiappacassi, Monica, Baldassarre, Gustavo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540908/ https://www.ncbi.nlm.nih.gov/pubmed/28769043 http://dx.doi.org/10.1038/s41598-017-07005-1

Ejemplares similares

Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity
por: Pellarin, Ilenia, et al.
Publicado: (2020)

Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells
por: Lorenzon, Ilaria, et al.
Publicado: (2019)

CDK6 protects epithelial ovarian cancer from platinum‐induced death via FOXO3 regulation
por: Dall'Acqua, Alessandra, et al.
Publicado: (2017)

Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells
por: Ranzuglia, Valentina, et al.
Publicado: (2020)

Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo
por: Berton, Stefania, et al.
Publicado: (2014)

USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability
por: Sonego, Maura, et al.
Publicado: (2019)

CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review
por: Rampioni Vinciguerra, Gian Luca, et al.
Publicado: (2022)

Loss of p27(kip1) increases genomic instability and induces radio-resistance in luminal breast cancer cells
por: Berton, Stefania, et al.
Publicado: (2017)

TIMP-1 Is Overexpressed and Secreted by Platinum Resistant Epithelial Ovarian Cancer Cells
por: Sonego, Maura, et al.
Publicado: (2019)

p27(kip1) expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms
por: Pellizzari, Ilenia, et al.
Publicado: (2016)

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer
por: Viotto, Davide, et al.
Publicado: (2020)

Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives
por: Dall’Acqua, Alessandra, et al.
Publicado: (2021)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2014)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2013)

Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation
por: Segatto, Ilenia, et al.
Publicado: (2023)

Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling
por: Segatto, Ilenia, et al.
Publicado: (2014)

p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation
por: Segatto, Ilenia, et al.
Publicado: (2014)

Multiplex staining depicts the immune infiltrate in colitis-induced colon cancer model
por: Pivetta, Eliana, et al.
Publicado: (2019)

A new role for IDH1 in the control of ovarian cancer cells metabolism and senescence
por: Sonego, Maura, et al.
Publicado: (2020)

Role of T198 Modification in the Regulation of p27(Kip1) Protein Stability and Function
por: Schiappacassi, Monica, et al.
Publicado: (2011)

The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential
por: Dal Bo, Michele, et al.
Publicado: (2015)

p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer
por: Rampioni Vinciguerra, Gian Luca, et al.
Publicado: (2021)

Time-tuning cancer therapy
por: Baldassarre, Gustavo, et al.
Publicado: (2015)

STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context
por: Segatto, Ilenia, et al.
Publicado: (2018)

Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance
por: Zucchetto, Antonella, et al.
Publicado: (2006)

Hyaluronan–CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9
por: Spessotto, Paola, et al.
Publicado: (2002)

Functional osteoclastogenesis: the baseline variability in blood donor precursors is not associated with age and gender
por: Pivetta, Eliana, et al.
Publicado: (2015)

KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders
por: Vendramini, Elena, et al.
Publicado: (2022)

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer
por: Lombardi, Rita, et al.
Publicado: (2021)

Detection of Lyme Disease and Q Fever Agents in Wild Rodents in Central Italy
por: Pascucci, Ilaria, et al.
Publicado: (2015)

Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer
por: Segatto, Ilenia, et al.
Publicado: (2016)

Foliar Application of Silicon in Vitis vinifera: Targeted Metabolomics Analysis as a Tool to Investigate the Chemical Variations in Berries of Four Grapevine Cultivars
por: Sut, Stefania, et al.
Publicado: (2022)

HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel
por: Sgubin, Michela, et al.
Publicado: (2022)

The extracellular matrix protein EMILIN1 silences the RAS-ERK pathway via α4β1 integrin and decreases tumor cell growth
por: Modica, Teresa Maria Elisa, et al.
Publicado: (2017)

pCLE detects mucosal neoplastic vascular pattern in gastric linitis plastica
por: Fornasarig, Mara, et al.
Publicado: (2022)

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis
por: Bartoletti, Michele, et al.
Publicado: (2020)

An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy
por: Cohen, Jared A., et al.
Publicado: (2020)

TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
por: Bomben, Riccardo, et al.
Publicado: (2023)

Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors
por: Cusan, Martina, et al.
Publicado: (2018)

p27kip1 at the crossroad between actin and microtubule dynamics
por: Rampioni Vinciguerra, Gian Luca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_trepv9p9r3sn3ksiq09dc1f0em